Biosyent Inc
XTSX:RX

Watchlist Manager
Biosyent Inc Logo
Biosyent Inc
XTSX:RX
Watchlist
Price: 11.55 CAD -0.86% Market Closed
Market Cap: 133.9m CAD
Have any thoughts about
Biosyent Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Biosyent Inc

Current Assets 27.6m
Cash & Short-Term Investments 17.1m
Receivables 4.4m
Other Current Assets 6.1m
Non-Current Assets 17.9m
Long-Term Investments 10.5m
PP&E 1.3m
Intangibles 5.7m
Other Non-Current Assets 458.2k
Current Liabilities 7m
Accounts Payable 6.3m
Other Current Liabilities 783k
Non-Current Liabilities 1.1m
Long-Term Debt 892.9k
Other Non-Current Liabilities 197.3k

Balance Sheet
Biosyent Inc

Rotate your device to view
Balance Sheet
Currency: CAD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
7
4
13
9
9
11
10
14
5
5
Cash
7
4
13
9
9
11
10
14
5
5
Short-Term Investments
1
5
1
10
15
11
15
14
23
21
Total Receivables
1
1
2
2
2
2
2
3
4
4
Accounts Receivables
1
1
2
2
2
2
2
2
3
3
Other Receivables
0
0
0
0
0
0
0
1
1
0
Inventory
1
2
2
1
1
2
2
2
5
6
Other Current Assets
0
0
0
0
0
1
0
0
0
0
Total Current Assets
10
13
18
23
28
27
30
34
37
36
PP&E Net
0
0
0
0
0
2
2
2
2
1
PP&E Gross
0
0
0
0
0
2
2
2
2
1
Accumulated Depreciation
0
0
0
0
0
1
1
1
2
2
Intangible Assets
0
1
1
2
2
1
1
1
1
1
Note Receivable
0
0
0
0
1
1
1
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
0
0
3
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
11
N/A
15
+37%
19
+32%
25
+30%
31
+24%
31
-1%
34
+8%
37
+11%
40
+9%
42
+3%
Liabilities
Accounts Payable
2
2
2
3
3
3
4
4
5
5
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
1
0
0
0
Total Current Liabilities
2
2
2
3
3
3
5
4
6
6
Long-Term Debt
0
0
0
0
0
2
2
1
1
1
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Total Liabilities
2
N/A
2
-1%
3
+3%
3
+15%
4
+24%
5
+44%
7
+31%
6
-17%
7
+27%
7
-5%
Equity
Common Stock
7
7
7
8
8
7
6
6
5
5
Retained Earnings
1
4
9
14
19
17
19
24
26
28
Additional Paid In Capital
0
0
1
1
1
1
1
2
2
2
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
8
N/A
12
+49%
17
+38%
22
+33%
28
+24%
26
-7%
27
+4%
32
+18%
33
+6%
35
+4%
Total Liabilities & Equity
11
N/A
15
+37%
19
+32%
25
+30%
31
+24%
31
-1%
34
+8%
37
+11%
40
+9%
42
+3%
Shares Outstanding
Common Shares Outstanding
14
14
14
15
14
14
13
13
12
12

See Also

Discover More